Revolution Medicines RVMD 深 沪
已收盘 07-02 16:00:00 美东时间
189.24
+1.730
+0.92%
华盛通- 最 高189.4826
- 今 开188.37
- 成交量 319.08万股
- 最 低 184.285
- 昨 收 187.51
- 总市值 402.32亿
- 52周最高 193.095
- 市盈率 静 --
- 换手率 1.50%
- 52周最低 34.00
- 委 比 -67.37%
- 总股本 2.13亿
- 历史最高 193.095
- 量 比 0.60
- 振 幅 2.77%
- 历史最低 14.08
- 每 手 1
- 风险率 42.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | Bernstein上调闪迪目标价从1700美元升至3000美元；大摩上调谷歌-A目标价从375美元升至415美元
今日重点评级关注：Citizens：维持DBV Technologies"跑赢大市"评级，目标价从47美元升至55美元；康托·菲茨杰拉德：维持BioCryst制药"超配"评级，目标价从27美元升至29美元
07-01 10:40
美股大行评级 | 康托·菲茨杰拉德大幅上调AMD、英特尔、迈威尔科技、美光、西部数据目标价！Applied、INIO、LFTO、Quantinuum获多家大行首予买入评级
今日重点评级关注：Evercore ISI集团：维持ProQR Therapeutics"跑赢大市"评级，目标价从5美元升至6美元；摩根士丹利：维持霍尼韦尔"标配"评级，目标价从245美元升至490美元
06-30 10:14
Needham Maintains Buy on Revolution Medicines, Raises Price Target to $235
Needham analyst Ami Fadia maintains Revolution Medicines (NASDAQ:RVMD) with a Buy and raises the price target from $183 to $235.
06-29 18:24
Biotech breakout: iShares Biotechnology ETF hits all-time high
The biotechnology sector continued its advance on Tuesday, with the iShares Biotechnology ETF (IBB) reaching a record intraday high of $179.95 as investor interest in the industry remained strong. The...
06-24 02:52
Revolution Medicines Announces Planned Leadership Transition for Steve Kelsey, M.D.
Revolution Medicines announces Steve Kelsey, M.D., president of R&D, will transition to senior advisor to CEO effective July 1, 2026, prior to his planned retirement in January 2027. Dr. Kelsey, who has led the company’s R&D since 2017, will continue to contribute his insights during the transition. The company will implement a new R&D leadership structure, with Alan Sandler, Jan Smith, and Xiaolin Wang assuming expanded roles. Revolution Medicin...
06-22 12:00
$1000 Invested In Revolution Medicines 5 Years Ago Would Be Worth This Much Today
Revolution Medicines (NASDAQ:RVMD) has outperformed the market over the past 5 years by 25.06% on an annualized basis producing an average annual return of 37.04%. Currently, Revolution Medicines has a market capitalization of $33.84 billion. Buying $1000 In RVMD: If an investor had bought $1000 of ...
06-18 22:45
美股大行评级 | 高盛上调美光科技目标价从400美元升至900美元；斯马克、Cloudflare获多家公司上调目标价
今日重点评级关注：Ascendiant Capital：维持NextTrip"买入"评级，目标价从7美元升至7.5美元；Maxim Group：维持Zevra Therapeutics"买入"评级，目标价从25美元升至35美元
06-11 09:55
Regeneron-backed Parabilis surges after record-setting IPO
Parabilis Medicines (PBLS) climbed more than 45% in its first trading session on Wednesday after the cancer drug developer backed by a recent research deal with Regeneron (REGN) made its public debut ...
06-11 01:30
BUZZ-IDEAYA Biosciences drops on $300 mln equity raise
BUZZ-IDEAYA Biosciences drops on $300 mln equity raise ** IDEAYA Biosciences' IDYA.O shares down 9.8% before the bell on Tues to $28.40 after $300 mln overnight follow-on priced ** IDYA late Mon sold ~5.56 mln shares and pre-funded warrants to buy ~5.56 mln shares at $27, a 14.2% discount to last sa
06-09 18:51
